Nattokinase Vitamins: Benefits, Safety & Dosage

You have probably seen nattokinase vitamins showing up everywhere — on supplement shelves, in health forums, and even in conversations with friends who swear by them for heart health. But the moment you start researching, things get confusing fast. What are fibrinolytic units (FU)? Is nattokinase the same as vitamin K2? Should you take it if you are already on blood thinners? And why do some doctors seem cautious about recommending it despite centuries of traditional use in Japan?

The challenge is that most nattokinase guides either oversimplify the science or bury you in jargon — and almost none draw from the Japanese research where this enzyme was first discovered and has been studied most deeply.

We reviewed the clinical evidence on nattokinase, including meta-analyses, randomized controlled trials, and Japanese academic papers rarely covered in English-language resources, to give you a clear, evidence-based picture of what nattokinase can and cannot do. This guide covers the benefits supported by research, the safety considerations you need to know, how to understand dosing in FU, and what Japanese research reveals about quality standards that most guides overlook.

What Is Nattokinase?

From Natto to Supplement

Nattokinase is a fibrinolytic enzyme — meaning it has the ability to break down fibrin, the protein meshwork that holds blood clots together. It is produced naturally during the fermentation of soybeans by Bacillus subtilis var. natto, the same bacterial strain used to make natto, a traditional Japanese food that has been consumed for centuries ^[1].

The enzyme was discovered in 1980 by Professor Hiroyuki Sumi, then a researcher at the University of Chicago Medical School. He placed a sample of natto on an artificial blood clot (fibrin plate) and observed that it dissolved the clot within 18 hours. He published his findings in 1986, identifying nattokinase as the first food-derived thrombolytic enzyme ever documented ^[21]. Professor Sumi estimated that one serving of natto (approximately 100 grams) provides fibrinolytic activity equivalent to the pharmaceutical thrombolytic agent urokinase View source.

As a supplement, nattokinase is extracted and purified from the natto fermentation process. It is a 275-amino acid serine protease enzyme with a molecular weight of approximately 27.7 kDa, belonging to the subtilisin family ^[1].

Understanding FU (Fibrinolytic Units)

If you have ever looked at a nattokinase supplement label, you have noticed the unit "FU" — Fibrinolytic Units. This is the standardized measurement of nattokinase's ability to degrade fibrin, and it is the most important number on the label ^[2].

Here is how common supplement strengths compare:

The key number to remember: Clinical trials have used dosages ranging from 1,200 to 10,800 FU daily, with 2,000 FU being the most commonly studied dose ^[8]. The Japan NattoKinase Association (JNKA) sets a quality standard of 20,000 FU per gram or higher for certified products View source.

How Nattokinase Works

Nattokinase does not work through a single mechanism — it acts on the cardiovascular system through multiple pathways ^[1][7]02699-9):

Direct fibrinolysis. Nattokinase directly cleaves and degrades fibrin, the structural protein in blood clots. This is its most extensively studied mechanism and the reason it is classified as a fibrinolytic enzyme ^[1].

Plasminogen activation. Beyond direct action, nattokinase also activates the body's own clot-dissolving system by converting tissue plasminogen activator (t-PA) pro-enzyme to its active form. This amplifies the natural fibrinolytic process ^[1].

Anticoagulant effects. Research shows nattokinase reduces clotting factors VII and VIII, decreasing the blood's tendency to form new clots ^[1].

Anti-inflammatory properties. Emerging evidence suggests nattokinase also reduces inflammatory markers that contribute to cardiovascular disease progression ^[2].

How quickly does it act? A Japanese clinical study demonstrated that a single oral dose of 2,000 FU produced measurable increases in fibrin degradation products within 4 hours (p < .05). Pharmacokinetic data suggests peak serum levels are reached at approximately 13.3 hours after oral administration, indicating sustained systemic exposure ^[1].

Evidence-Based Benefits of Nattokinase

Blood Pressure Support: Strong Evidence

Blood pressure reduction is the best-supported benefit of nattokinase, backed by Level 1 evidence from a meta-analysis.

A meta-analysis of 6 randomized controlled trials involving 546 participants found nattokinase supplementation produced significant reductions in both systolic and diastolic blood pressure: SBP decreased by 3.45 mmHg (95% CI: -4.37 to -2.18, p < 0.00001) and DBP decreased by 2.32 mmHg (95% CI: -2.72 to -1.92, p < 0.00001). The researchers concluded that nattokinase is an "effective adjunctive therapy for hypertension" ^[2].

Two landmark RCTs independently support these findings. A study in Korean adults with pre-hypertension or stage 1 hypertension found clinically meaningful blood pressure reductions with nattokinase supplementation ^[3]. A multicenter, double-blind, placebo-controlled trial in a North American population found significant reductions in both systolic and diastolic blood pressure, as well as von Willebrand factor, a cardiovascular risk marker ^[4].

An important nuance: The NAPS trial (265 participants, 3 years at 2,000 FU) did not find significant blood pressure effects at this dose ^[9]. This suggests that dose may matter — clinical trials showing positive results used a range of 1,200 to 8,000 FU daily.

A 3-4 mmHg reduction in systolic blood pressure may sound modest, but population-level data shows that even small sustained reductions in blood pressure meaningfully lower cardiovascular risk over time.

Blood Clot Prevention and Circulation: Moderate to Strong Evidence

Nattokinase's fibrinolytic activity is its most historically studied property, with a substantial body of evidence:

A clinical study of 1,062 participants found that nattokinase reduced common carotid artery intima-media thickness and carotid plaque size at doses of 6,000 to 7,000 FU over 12 months ^[10]. An observational study of 153 patients with vascular disease taking 100 mg per day of nattokinase for an extended period reported no adverse events, with coagulation parameters remaining within normal range ^[11].

A Japanese clinical study in healthy subjects demonstrated that nattokinase supplementation improved blood flow parameters ^[25].

The evidence is not all one-sided. The NAPS trial — the largest and most rigorous RCT to date with 265 participants followed for 3 years at 2,000 FU daily — did not show significant reduction in subclinical atherosclerosis progression compared to placebo ^[9]. This is an important result to acknowledge. The discrepancy between the 1,062-participant clinical study (positive at 6,000-7,000 FU) and the NAPS trial (negative at 2,000 FU) suggests that dose may be a critical factor in achieving cardiovascular benefits.

Cholesterol and Lipid Management: Emerging Evidence

The evidence for nattokinase's lipid-lowering effects is mixed and appears to be dose-dependent.

The meta-analysis of 6 RCTs found no significant lipid-lowering effect at relatively standard doses of 1,200 to 4,000 FU ^[2]. However, the 1,062-participant study reported that nattokinase at higher doses of 6,000 to 7,000 FU was effective at lowering total cholesterol, triglycerides, and LDL cholesterol in patients with hyperlipidemia over 12 months ^[10].

A randomized, double-blind, placebo-controlled trial found that nattokinase combined with red yeast rice (Monascus) produced significant improvements in lipid profiles over 4 months ^[5]. Another RCT of 189 patients with coronary artery disease found that the nattokinase-red yeast rice combination significantly reduced cardiac biomarkers LDH and CK (p < 0.01 for LDH, p < 0.0001 for CK) over 90 days ^[6].

Bottom line: Standard nattokinase dosing (2,000-4,000 FU) alone is unlikely to produce significant lipid improvements. Higher doses or combination approaches show more promise, but the evidence remains emerging.

Anti-Inflammatory Effects: Emerging Evidence

A review of nattokinase's anti-inflammatory and antioxidant effects found supporting evidence from both in vitro and clinical studies for its role as an adjuvant therapeutic strategy for non-communicable diseases ^[14]. The clinical study of 189 patients with coronary artery disease showed significant reductions in cardiac inflammatory biomarkers, suggesting that nattokinase may contribute to cardiovascular protection beyond just clot prevention ^[6].

However, dedicated anti-inflammatory RCTs for nattokinase alone are limited. Most positive data comes from combination studies or in vitro work.

Cognitive Health: Preliminary Evidence

A recently published randomized controlled trial — the first to evaluate cognitive effects of nattokinase — found that supplementation may contribute to improving visuospatial function in patients with asymptomatic intracranial or carotid artery stenosis ^[24]. This is an intriguing finding, but with only a single RCT published, it should be considered preliminary. More research is needed before any conclusions can be drawn about nattokinase and cognitive health.

Nattokinase Dosage: How Much to Take

Recommended Dosing from Clinical Research

The most commonly recommended starting dose is 2,000 FU (approximately 100 mg) daily. This dose has the deepest safety data, including a 3-year study with 265 participants ^[9] and extended observation in 153 vascular disease patients ^[11].

When and How to Take Nattokinase

• Frequency: Typically taken once or twice daily
• With food: Nattokinase can be taken with or without food
• Duration of effects: Japanese research suggests that the fibrinolytic effects of a single dose last approximately 2 to 8 hours ^[23]
• Peak blood levels: Pharmacokinetic data shows peak serum concentrations at approximately 13 hours after oral administration ^[1]

Important: Always start with the standard dose (2,000 FU) and consult a healthcare provider before increasing, especially if you take any medications.

How Long Until You See Results?

One of the most common questions about nattokinase — and one that most guides fail to address — is how long you need to take it before noticing effects. Based on clinical trial timelines, here is what the evidence suggests:

Set realistic expectations: Acute fibrinolytic effects occur quickly, but cardiovascular benefits like blood pressure reduction require consistent daily use over weeks to months. Nattokinase is not a fast-acting intervention — it works through gradual, sustained biochemical changes.

Safety Considerations

Common Side Effects

Based on clinical trial data across multiple studies, nattokinase is generally well-tolerated at standard doses. A comprehensive toxicological assessment (GLP-compliant rodent studies and human administration) found no adverse effects and concluded that nattokinase is "generally recognized as safe" at standard doses ^[12].

The most commonly reported side effects include mild gastrointestinal issues such as nausea, bloating, or diarrhea, occurring in a small percentage of users ^[1]. In the 3-year NAPS trial (265 participants, 2,000 FU daily), no significant safety concerns were identified ^[9]. A real-world study of 153 patients with vascular disease taking 100 mg daily reported zero adverse events, with coagulation parameters remaining within normal range ^[11].

Drug Interactions

This is the most critical safety section. Nattokinase has significant interaction potential with medications that affect blood clotting:

^[16]

Who Should Avoid Nattokinase

• People with bleeding disorders — Nattokinase may worsen clotting dysfunction ^[1]
• Before surgery — Stop nattokinase at least 2 weeks before any scheduled surgical procedure due to bleeding and blood pressure risks ^[16]
• Soy allergy sufferers — Nattokinase is derived from soy fermentation and carries a risk of anaphylaxis or urticaria ^[16]
• People with a history of deep vein thrombosis — There is a theoretical risk of clot dislodgement ^[16]
• Mechanical heart valve patients — A case report documented thrombus formation when a patient substituted nattokinase for their prescribed warfarin after valve surgery ^[16]

Pregnancy and Nursing

There is insufficient safety data for nattokinase use during pregnancy or breastfeeding. No clinical trials have been conducted in pregnant or nursing women. Due to the theoretical bleeding risk, nattokinase is generally not recommended for this population. Consult your healthcare provider before use ^[1].

Why Some Doctors Are Cautious About Nattokinase

This is a fair question — and understanding the reasons actually helps you make a more informed decision:

1. Limited large-scale RCTs. Most nattokinase studies are relatively small (under 200 participants). The largest RCT (NAPS, 265 participants over 3 years) showed no significant benefit for atherosclerosis prevention ^[9].
2. Bleeding risk. While rare, it is a serious concern — especially for patients already taking anticoagulants ^[1].
3. Variable supplement quality. Unlike prescription medications, supplements are not regulated by the FDA for purity or potency. Product quality varies significantly across brands ^[16].
4. Drug interaction potential. Combining nattokinase with anticoagulants can dangerously enhance bleeding risk ^[1].
5. Serious adverse event case reports. Although rare and often involving comorbidities or polypharmacy, documented cases include fatal internal bleeding, cerebellar hemorrhage (combined with aspirin), and thrombus on a mechanical heart valve (self-substituted for warfarin) ^[16].
6. It is not a drug substitute. Nattokinase cannot replace prescribed blood thinners — case reports of serious harm when patients self-substituted demonstrate this clearly.

These are legitimate concerns, not dismissals of nattokinase's potential. The research is genuinely promising for blood pressure and fibrinolytic support, but it does not yet meet the evidence threshold that most physicians require for a formal recommendation.

The Nattokinase and Vitamin K2 Connection

One of the most common points of confusion — and a frequent question in online searches — is the relationship between nattokinase and vitamin K2. They are not the same thing, and understanding the difference matters for your safety.

Nattokinase is an enzyme (a serine protease) with fibrinolytic effects — it helps dissolve blood clots.

Vitamin K2 (menaquinone-7 or MK-7) is a fat-soluble vitamin that supports bone health and promotes blood coagulation by activating clotting factors.

Both substances are produced naturally during the fermentation of soybeans into natto. They coexist in the traditional food. But here is the critical point: they have opposite effects on blood clotting. Nattokinase dissolves clots, while vitamin K2 promotes clotting View source.

This distinction has practical implications:

• Japanese nattokinase supplements typically remove vitamin K2 during processing. This is done specifically for the safety of people taking anticoagulant medications like warfarin, since vitamin K2 interferes with these drugs View source.
• Some products sold internationally deliberately combine nattokinase with vitamin K2, marketing them as complementary for cardiovascular and bone health.
• If you take warfarin or other anticoagulants, a nattokinase supplement that also contains vitamin K2 could counteract your medication. Check the label carefully.

When shopping for nattokinase supplements, look at whether the product contains added vitamin K2 — and consider whether that combination is appropriate for your health situation.

What Japanese Research Reveals About Nattokinase

Nattokinase was discovered in Japan, and Japan remains the center of research and manufacturing expertise for this enzyme. Most English-language guides draw primarily from international clinical trials — but Japanese academic and regulatory sources offer insights that add meaningful context for anyone considering nattokinase supplements.

The JNKA Quality Standard Has No International Equivalent

The Japan NattoKinase Association (JNKA) certifies nattokinase products based on a standard of 20,000 FU per gram or higher for raw materials. This certification includes manufacturing process audits and quality testing. No equivalent certification body exists in international supplement markets, where product quality varies widely and is not subject to the same standardized testing View source.

Why this matters: When comparing products, a JNKA-certified nattokinase supplement has been verified against a defined potency standard. Without such certification, the FU count on a label may not be independently validated.

Japanese Supplements Approach Vitamin K2 Removal Differently

As discussed above, Japanese manufacturers pioneered the process of removing vitamin K2 during nattokinase extraction. This is standard practice in the Japanese supplement market, where the safety implications for warfarin users are well-understood and proactively addressed. Many international products take the opposite approach, adding K2 back in for marketing purposes View source.

Why this matters: This is not just a formulation choice — it reflects a safety-first approach to supplement design that prioritizes the needs of the most vulnerable users.

Japan Has a Structured Regulatory Pathway for Nattokinase Claims

While the FDA treats nattokinase as an unregulated dietary supplement with no approved health claims, Japan's Consumer Affairs Agency (消費者庁) has accepted 機能性表示食品 (Foods with Function Claims) filings for nattokinase products ^[17]. This means Japanese manufacturers can make specific health claims backed by submitted evidence through a structured regulatory review process. It represents a more transparent framework for supplement oversight compared to markets where supplements exist in a regulatory gray zone.

Why this matters: Regulatory frameworks influence product quality. Markets with structured oversight tend to produce supplements with more reliable potency and clearer labeling.

The Discovery Story Provides Important Scientific Context

Professor Hiroyuki Sumi's discovery of nattokinase in 1980 was not an accident — it emerged from systematic research into fibrinolytic enzymes at the University of Chicago. His subsequent decades of work at Japanese institutions established the foundational biochemistry that all current nattokinase research builds upon. He received Japan's Medal of Honor with Purple Ribbon (瑞宝小綬章) for his contributions to this field View source.

Why this matters: Understanding that nattokinase research has a 45-year scientific foundation — rooted in rigorous enzyme characterization rather than traditional medicine folklore — provides appropriate context for evaluating the evidence.

Japanese Activity Measurement Methods Underpin Global Standardization

The FU (Fibrinolytic Unit) system used worldwide to measure nattokinase potency was developed through Japanese research. The original activity measurement methods were published in Japanese scientific journals and later adopted internationally ^[22].

Why this matters: When you see "2,000 FU" on a supplement label anywhere in the world, that measurement traces back to Japanese analytical methods. Japan did not just discover nattokinase — it created the tools to measure and standardize it.

Our Recommendations

After reviewing the clinical evidence and Japanese research, we selected three nattokinase supplements from our collection, each suited to different needs.

Kobayashi Nattokinase EX

Why We Selected This: From Kobayashi Pharmaceutical, one of Japan's most established pharmaceutical companies with over 100 years of history. We chose this for customers who want a comprehensive cardiovascular support formula. Kobayashi's Nattokinase EX combines nattokinase with DHA and EPA, providing multi-pathway cardiovascular support in a single daily supplement. The pharmaceutical-grade manufacturing standards and Kobayashi's reputation for quality control make this a trusted choice.

Kobayashi is known for their rigorous quality standards, and this product reflects their pharmaceutical heritage — precise dosing, clean formulation, and transparent labeling.

View Kobayashi Nattokinase EX →

ORIHIRO Japanese Nattokinase 4000

Why We Selected This: ORIHIRO's Nattokinase 4000 delivers 4,000 FU per serving — double the standard clinical trial dose. For those looking for higher-potency nattokinase based on the research suggesting dose-dependent benefits (particularly for lipid management), this offers a convenient option. ORIHIRO is a well-known Japanese health food manufacturer with decades of experience in enzyme-based supplements.

View ORIHIRO Japanese Nattokinase 4000 →

Noguchi Nattokinase HQ

Why We Selected This: From the Noguchi brand, this premium nattokinase supplement focuses on high-quality nattokinase extraction. It is suitable for customers who want a straightforward, focused nattokinase supplement without additional ingredients. The clean formulation makes it easy to combine with your existing supplement routine.

View Noguchi Nattokinase HQ →

Product Comparison

Conclusion

Nattokinase is a genuinely promising natural enzyme with a 45-year scientific foundation rooted in Japanese research. The strongest clinical evidence supports its use for blood pressure reduction, with a meta-analysis confirming modest but significant effects across multiple randomized controlled trials. Its fibrinolytic properties are well-documented, and emerging research hints at potential benefits for lipid management and cardiovascular health at higher doses.

The key insights from our review: blood pressure support has the best evidence; dose matters more than most guides acknowledge; the nattokinase-vitamin K2 distinction is a safety consideration that deserves more attention; and Japanese quality standards, particularly JNKA certification, offer a level of product verification that international markets lack.

Nattokinase is not a cure, not a replacement for prescribed medications, and not right for everyone — particularly those on blood thinners or with bleeding disorders. But for health-conscious adults looking to support cardiovascular wellness with an evidence-based supplement, it represents one of the more researched natural options available.

This article is for informational purposes only and does not constitute medical advice. Consult a healthcare professional before starting any new health regimen, especially if you have existing health conditions or take medications. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.